Brain Inspired BI 218 Chris Rozell: Brain Stimulation and AI for Mental Disorders
20 snips
Aug 13, 2025 Chris Rozell leads the Structured Information for Precision Neuroengineering Lab at Georgia Tech and is the inaugural director of the Institute for Neuroscience, Neurotechnology, and Society. He discusses groundbreaking methods using deep brain stimulation and AI to treat treatment-resistant depression. Chris highlights how neural signals can predict treatment effectiveness and the importance of personalized care in mental health. Their conversation delves into the evolving techniques in neuromodulation and the necessity of interdisciplinary research to enhance future therapies.
AI Snips
Chapters
Transcript
Episode notes
Objective Measures To Support Psychiatry
- Psychiatry lacks objective biomarkers that clinicians can trust in real time.
- Rozell stresses that objective brain measures could supplement clinicians' judgment and inform treatment adjustments.
Favor Human-In-The-Loop For Slow Recoveries
- Use slow, human-in-the-loop adjustments rather than immediate automatic changes when disease recovery is slow.
- Provide clinicians with decision support tools before attempting fully autonomous closed-loop DBS.
Short-Term Effects Differ From Long-Term Recovery
- Acute electrophysiological effects of stimulation can differ from long-term recovery signatures.
- Longitudinal recordings revealed an initial beta suppression followed by beta increases that correlate with stable recovery.
